Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
250 participants
INTERVENTIONAL
2025-10-21
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
iCare IC1000 vs GAT, iCare IC200 and Perkins
iCare IC1000
Measurement of Intraocular Pressure (IOP) in sitting and supine position
iCare IC200
Measurement of Intraocular Pressure (IOP) in sitting and supine position
GAT
Measurement of Intraocular Pressure (IOP) in sitting position
Perkins
Measurement of Intraocular Pressure (IOP) in supine position
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iCare IC1000
Measurement of Intraocular Pressure (IOP) in sitting and supine position
iCare IC200
Measurement of Intraocular Pressure (IOP) in sitting and supine position
GAT
Measurement of Intraocular Pressure (IOP) in sitting position
Perkins
Measurement of Intraocular Pressure (IOP) in supine position
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Subjects having poor or eccentric fixation in the study eye
* High corneal astigmatism \>3D in the study eye
* Central corneal scarring
* History of prior incisional glaucoma surgery or corneal surgery, including corneal refractive laser surgery in the study eye
* Microphthalmos
* Buphthalmos
* Contact lens use within one week of continuous wear and within one hour if lens is worn occasionally
* Dry eyes (clinically significant)
* Lid squeezers - blepharospasm
* Nystagmus
* Keratoconus
* Any other corneal or conjunctival pathology or infection relevant to this study
* Central corneal thickness greater than 600 µm or less than 500 µm in the study eye
* Cataract Extraction within last 2 months in the study eye
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Icare Finland Oy
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nova Scotia Health/Dalhousie University
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Balwantray Chauhan, Prof.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TA032-135
Identifier Type: -
Identifier Source: org_study_id